TELO · Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals Inc Is A Preclinical-Stage Biotechnology Company Focused On The Development Of Small-Molecule Therapeutics Designed To Address Upstream Biological Drivers Of Aging And Age-Related Diseases Rather Than Treating Symptoms Alone. The Company'S Research Targets Fundamental Cellular Processes Associated With Disease Progression And Functional Decline, Including Metal-Ion Dysregulation, Oxidative Stress, Epigenetic Regulation, Mitochondrial Dysfunction, And Telomere Integrity. Telomir'S Investigational Compound, Telomir-1 (Zn-Telomir), Is A Novel Orally Administered Small Molecule Engineered To Modulate Intracellular Metal Balance Particularly Iron, Copper, Calcium, And Zinc.